CIBC World Markets Inc. Buys 3,835 Shares of HealthSouth Corporation (HLS)

CIBC World Markets Inc. grew its stake in shares of HealthSouth Corporation (NYSE:HLS) by 7.9% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 52,492 shares of the company’s stock after buying an additional 3,835 shares during the period. CIBC World Markets Inc. owned 0.05% of HealthSouth Corporation worth $2,541,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in HLS. Wellington Management Group LLP increased its position in HealthSouth Corporation by 4,377.7% during the first quarter. Wellington Management Group LLP now owns 995,082 shares of the company’s stock worth $42,599,000 after buying an additional 972,859 shares in the last quarter. Mackay Shields LLC purchased a new position in HealthSouth Corporation during the second quarter worth $39,641,000. William Blair Investment Management LLC increased its position in HealthSouth Corporation by 13.9% during the second quarter. William Blair Investment Management LLC now owns 4,302,756 shares of the company’s stock worth $208,253,000 after buying an additional 525,767 shares in the last quarter. Marshall Wace North America L.P. increased its position in HealthSouth Corporation by 311.3% during the second quarter. Marshall Wace North America L.P. now owns 560,568 shares of the company’s stock worth $26,907,000 after buying an additional 424,280 shares in the last quarter. Finally, Deprince Race & Zollo Inc. purchased a new position in HealthSouth Corporation during the first quarter worth $16,129,000. 93.10% of the stock is owned by institutional investors.

Several research firms have weighed in on HLS. KeyCorp reissued a “hold” rating on shares of HealthSouth Corporation in a research report on Thursday, September 7th. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $55.00 price objective on shares of HealthSouth Corporation in a research report on Wednesday, September 6th. ValuEngine downgraded HealthSouth Corporation from a “buy” rating to a “hold” rating in a research report on Friday, September 1st. Stephens assumed coverage on HealthSouth Corporation in a research report on Thursday, August 31st. They issued an “overweight” rating and a $53.00 price objective for the company. Finally, Zacks Investment Research downgraded HealthSouth Corporation from a “buy” rating to a “hold” rating in a research report on Tuesday, August 15th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $49.71.

In other HealthSouth Corporation news, CEO Mark J. Tarr sold 22,625 shares of the business’s stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $42.55, for a total transaction of $962,693.75. Following the sale, the chief executive officer now directly owns 283,134 shares of the company’s stock, valued at approximately $12,047,351.70. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 1.60% of the stock is owned by insiders.

ILLEGAL ACTIVITY NOTICE: This piece was originally published by Markets Daily and is owned by of Markets Daily. If you are accessing this piece on another site, it was stolen and reposted in violation of United States and international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.themarketsdaily.com/2017/09/12/cibc-world-markets-inc-buys-3835-shares-of-healthsouth-corporation-hls.html.

Shares of HealthSouth Corporation (NYSE HLS) opened at 45.42 on Tuesday. The stock has a 50 day moving average price of $44.05 and a 200-day moving average price of $44.85. The stock has a market cap of $4.48 billion, a P/E ratio of 16.55 and a beta of 0.59. HealthSouth Corporation has a 12 month low of $36.97 and a 12 month high of $49.71.

HealthSouth Corporation (NYSE:HLS) last announced its earnings results on Monday, July 31st. The company reported $0.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.68 by $0.03. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. The company had revenue of $981.30 million for the quarter, compared to the consensus estimate of $976.46 million. During the same period in the previous year, the business earned $0.69 EPS. The company’s revenue was up 6.6% on a year-over-year basis. On average, analysts forecast that HealthSouth Corporation will post $2.71 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Monday, October 2nd will be paid a dividend of $0.25 per share. This is an increase from HealthSouth Corporation’s previous quarterly dividend of $0.24. This represents a $1.00 annualized dividend and a yield of 2.20%. The ex-dividend date of this dividend is Friday, September 29th. HealthSouth Corporation’s payout ratio is 35.29%.

HealthSouth Corporation Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Institutional Ownership by Quarter for HealthSouth Corporation (NYSE:HLS)

Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply